Vinorelbine

In the US, Vinorelbine (vinorelbine systemic) is a member of the drug class mitotic inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

• Vinorelbine


• Vinorelbine Intravenous


• Vinorelbine Tartrate

UK matches:

• Vinorelbine 10mg/ml concentrate for solution for infusion (Actavis UK Ltd)
• Vinorelbine 10 mg/ml Concentrate for solution for infusion (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01CA04

CAS registry number (Chemical Abstracts Service)

0071486-22-1

Chemical Formula

C45-H54-N4-O8

Molecular Weight

778

Therapeutic Category

Antineoplastic agent, microtubule inhibitor

Chemical Name

3',4'-Didehydro-4'-deoxy-8'-norvincaleukoblastine

Foreign Names

• Vinorelbinum (Latin)
• Vinorelbin (German)
• Vinorelbine (French)
• Vinorelbina (Spanish)

Generic Names

• Vinorelbine (OS: DCF, BAN)
• 5'-Noranhydrovinblastine (IS)
• KW 2307 (IS)
• Vinorelbine (PH: USP 28)
• Vinorelbine Tartrate (OS: BANM, USAN)
• Didehydrodeoxynorvincaleukoblastine (IS)
• Vinorelbin bitartrate (IS)
• Vinorelbine Tartrate (PH: BP 2010, USP 32, Ph. Eur. 6)
• Vinorelbini tartras (PH: Ph. Eur. 6)

Brand Names

• Eunexon
  AC Farma, Peru



• Maverex
  Verofarm, Russian Federation



• Navelbine
  PF, Luxembourg; Pierre Fabre, Germany; Pierre Fabre, Denmark; Pierre Fabre, Spain; Pierre Fabre, Israel; Pierre Fabre, Poland; Pierre Fabre, Romania; Pierre Fabre, Singapore; Pierre Fabre, Tunisia; Pierre Fabre, Turkey; Pierre Fabre Medicament, Slovenia



• Navirel
  Medac, Czech Republic; Medac, Germany



• Tevarelbine
  Pharmachemie, Bulgaria



• Vilbine
  Richmond, Peru



• Vilne
  Dosa, Argentina



• Vinelbine
  Dabur, Georgia



• Vinorayne
  Hospira, Poland



• Vinorelbin Hexal
  Hexal, Germany



• Vinorelbin Hospira
  Hospira, Hungary



• Vinorelbin Sindan
  Sindan, Romania



• Vinorelbina Ferrer Farma
  Ferrer, Spain



• Vinorelbina Sandoz
  Sandoz, Colombia



• Vinorelbina
  Biocrom, Peru



• Vinorelbine Biocrom
  Biocrom, Argentina



• Bagovir
  Armstrong, Mexico



• Bendarelbin
  Bendalis, Germany



• Eberelbin
  Ebewe, Austria



• Filcrin
  Filaxis, Argentina



• Min Nuo Bin
  Minsheng, China



• Navelbin
  Pierre Fabre, Hungary



• Navelbine
  Baxter, Chile; Baxter, Philippines; Boehringer Ingelheim, Austria; GlaxoSmithKline, Guyana; Kyowa Hakko Kirin, Japan; Orient Europharma, Taiwan; Pierre Fabre, Argentina; Pierre Fabre, Australia; Pierre Fabre, Belgium; Pierre Fabre, Canada; Pierre Fabre, China; Pierre Fabre, Czech Republic; Pierre Fabre, Germany; Pierre Fabre, Denmark; Pierre Fabre, Estonia; Pierre Fabre, Finland; Pierre Fabre, United Kingdom; Pierre Fabre, Georgia; Pierre Fabre, Greece; Pierre Fabre, Iceland; Pierre Fabre, Italy; Pierre Fabre, Lithuania; Pierre Fabre, Latvia; Pierre Fabre, Malta; Pierre Fabre, Netherlands; Pierre Fabre, Norway; Pierre Fabre, Oman; Pierre Fabre, Poland; Pierre Fabre, Romania; Pierre Fabre, Russian Federation; Pierre Fabre, Sweden; Pierre Fabre, United States; Pierre Fabre, Vietnam; Pierre Fabre Medicament, Slovakia; Pierre Fabre Médicament, France; Pierre-Fabre, Mexico; Robapharm, Switzerland; Tema Medical, South Africa; Transfarma Medica Indah, Indonesia



• Navildez
  Cryopharma, Mexico



• Navin
  Cancernova, Germany



• Navirel
  Medac, Denmark; Medac, Finland; Medac, Netherlands; Medac, Norway; Medac, Poland; Medac, Sweden; Medac, Slovakia



• Neocitec
  Novartis, Brazil; Sandoz, Argentina



• Nibrevin
  Ingers, Czech Republic



• Norelbin
  Eurofarma, Brazil



• Riborelbin
  Ribosepharm, Germany



• Sulcoline
  Teva, Argentina



• Vinarine
  LKM, Argentina



• Vinelbine
  Dabur, India; Dabur, Myanmar



• Vinorelbin Actavis
  Actavis, Sweden



• Vinorelbin Caduceus
  Caduceus Pharma, Slovakia



• Vinorelbin cell pharm
  Cell pharm, Germany



• Vinorelbin DRAC
  Dermapharm, Switzerland



• Vinorelbin Ebewe
  Alliance, Poland; Ebewe, Czech Republic; Ebewe, Estonia; Ebewe, Hungary; Ebewe, Lithuania; Ebewe, Latvia; Ebewe, Slovenia; Ebewe Pharma, Denmark; Ebewe Pharma, Slovakia; Meda, Sweden; Sandoz, Switzerland



• Vinorelbin Hospira
  Hospira Nordic, Sweden



• Vinorelbin Mayne
  Hospira, Norway



• Vinorelbin Medac
  Medac, Austria; Medac, Hungary



• Vinorelbin NC
  NeoCorp, Germany



• Vinorelbin Sandoz
  Sandoz, Austria; Sandoz, Slovakia



• Vinorelbina Varifarma
  Varifarma, Argentina



• Vinorelbina
  Kampar, Chile



• Vinorelbin-Actavis
  Actavis, Austria; Actavis, Switzerland; Actavis, Germany



• Vinorelbine ActavisGroup
  Actavis Group, Netherlands



• Vinorelbine All-Gen
  All-Gen, Netherlands



• Vinorelbine Ebewe
  Ebewe, France; Ebewe, Netherlands; InterPharma, New Zealand



• Vinorelbine Hospira
  Hospira, Netherlands



• Vinorelbine Mayne
  Faulding, France



• Vinorelbine PCH
  Pharmachemie, Netherlands



• Vinorelbine Sandoz
  Sandoz, Netherlands



• Vinorelbine Tartrate
  Actavis, United States; APP, United States; Baxter, United States; Bedford, United States; Ebewe, United States; Hospira, Canada; Hospira, United States; Mayne, United States; Novopharm, Canada; Sicor, United States; Teva USA, United States



• Vinorelbine Teva
  Teva, Latvia; Teva Santé, France



• Vinorelbine
  Delta Farma, Argentina; Hospira, Australia; Mayne, Hong Kong; Medac, United Kingdom



• Vinorgen
  Bioprofarma, Argentina



• Vinotel
  Dabur, Philippines

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.